人I型胶原基因第一内含子调节转录的研究

人Ｉ型胶原α１（Ｉ）链（ＣＯＬＩＡ１）基因内含子序列在不同细胞内有不同的转录调节活性,报道了含人ＣＯＬＩＡ１基因内含子Ｉ不同区段（＋５４４～＋８５５和＋８２０～＋１０９３）的重组质粒ｐＳＣＥＰ－ＣＡＴ和ｐＳＣＩＰ－ＣＡＴ的构建并转染人胚肌腱成纤维细胞和Ｔｃａ８１１３舌癌细胞,地高辛标记抗ＣＡＴ－ＥＬＩＳＡ检测结果显示：ｐＳＣＥＰ－ＣＡＴ在两种细胞均获表达;ｐＳＣＩＰ－ＣＡＴ在人成纤维细胞未表达,但     

P~（53） PROTEIN OVEREXPRESSION IN PREMALIGNANT AND MALIGNANT LESIONS OF ORAL MUCOSA：IMMUNOHISTOCHEMICAL OBSERVATION

Ｐ~（５３）　ＰＲＯＴＥＩＮ　ＯＶＥＲＥＸＰＲＥＳＳＩＯＮ　ＩＮ　ＰＲＥＭＡＬＩＧＮＡＮＴ　ＡＮＤ　ＭＡＬＩＧＮＡＮＴ　ＬＥＳＩＯＮＳ　ＯＦ　ＯＲＡＬ　ＭＵＣＯＳＡ：ＩＭＭＵＮＯＨＩＳＴＯＣＨＥＭＩＣＡＬ　ＯＢＳＥＲＶＡＴＩＯＮＰ~（５３）ＰＲＯＴＥＩ...     

LI-6400光合作用测定系统:原理、性能、基本操作与常见故障的排除

ＬＩ┐６４００光合作用测定系统：原理、性能、基本操作与常见故障的排除蒋高明（中国科学院植物研究所,北京１０００９３）ＬＩ—６４００ＰＯＲＴＡＢＬＥＰＨＯＴＯＳＹＮＴＨＥＳＥＳＳＹＳＴＥＭ：ＰＲＩＮＣＩＰＬＥ,ＦＵＮＣＴＩＯＮ,ＢＡＳＩＣＯＰＥＲＡＴＩ...     

关于紫菜生活史的讨论

关于紫菜生活史的讨论钟恒（中山大学生物系,广州５１０２７５）ＮＯＴＥＳＯＮＴＨＥＬＩＦＥＣＹＣＬＥＯＦＰＯＲＰＨＹＲＡＺｈｏｎｇＨｅｎｇ（ＤｅｐａｒｔｍｅｎｔｏｆＢｉｏｌｏｇｙ,ＺｈｏｎｇｓｈａｎＵｎｉｖｅｒｓｉｔｙ,Ｇｕａｎｇｚｈｏｕ５１０２７５）...     

小鼠孤雌胚胎干细胞集落的建立

ＥＳＴＡＢＬＩＳＨＭＥＮＴＯＦＳＴＥＭＣＥＬＬＣＯＬＯＮＩＥＳＦＲＯＭＰＡＲＴＨＥＮＯＧＥＮＥＴＩＣＡＬＬＹＤＥＲＩＶＥＤＢＬＡＳＴＯＣＹＳＴＳＯＦＭＯＵＳＥ小鼠孤雌胚胎干细胞集落的建立ＫｅｙｗｏｒｄｓＭｏｕｓｅ,Ｐａｒｔｈｅｎｏｇｅｎｅｔｉｃｅｍ...     

抗寒剂在沈阳于洪区水稻上的试验总结

抗寒剂在沈阳于洪区水稻上的试验总结刘建华（沈阳市于洪区农业技术推广中心１１０１４１）ＴＨＥＥＸＰＥＲＩＭＥＮＴＳＯＦＴＨＥＣＯＬＤ－ＲＥＳＩＳＴＥＲＡＰＰＬＩＥＤＴＯＲＩＣＥＳＥＥＤＬＩＮＧＲＡＩＳＩＮＧＩＮＹＵＨＯＮＧＤＩＳＴＲＩＣＴＯＦＳＨＥＮＹ...     

多叶猴耳环──猴耳环属一新种

多叶猴耳环──猴耳环属一新种文和群（广西植物研究所分类研究室,桂林５４１００６）ＰＩＴＨＥＣＥＬＬＯＢＩＵＭＭＵＬＴＩＦＯＬＩＯＬＡＴＵＭ－ＡＮＥＷＳＰＥＣＩＥＳＯＦＰＩＴＨＥＣＥＬＬＯＢＩＵＭＦＲＯＭＧＵＡＮＧＸＩ,ＣＨＩＮＡＷｅｎＨｅｑｕｎ（Ｇｕ...     

网箱养鲤高产技术研究初报

网箱养鲤高产技术研究初报郭大民,卢自银,于仕彬,季荣岭（北京市水产总公司,１０１５１２）关键词网箱养鲤,高产技术ＰＲＥＬＩＭＩＮＡＲＹＲＥＰＯＲＴＯＮＨＩＧＨ－ＹＩＥＬＤＴＥＣＨＮＩＱＵＥＳＯＦＣＡＲＰＣＡＧＥＣＵＬＴＵＲＥ￥ＧｕｏＤａｍｉｎ;ＬｕＺ...     

＂植物抗寒剂＂新、陈药对早稻育秧效果的比较

＂植物抗寒剂＂新、陈药对早稻育秧效果的比较李志高（湖北省洪湖市农科所,４３３２００）ＡＣＯＭＰＡＲＩＳＯＮＢＥＴＷＥＥＮＴＨＥＥＦＦＣＴＳＯＦＴＨＥＮＥＷＰＲＯＤＵＣＴＳＡＮＤＯＬＤＰＲＯＤＵＣＴＳＯＦＴＨＥＣＯＬＤ－ＲＥＳＩＳＴＥＲＡＰＰＬＩＥＤＴ...     

促红细胞生成素基因表达载体的构建及其在CHO细胞中表达的研究

用从基因文库中所克隆的促红细胞生成素（ＥＰＯ）基因组基因,构建了３种由不同启动子调控的表达载体——ｐＯＰ１３／ＥＰＯ,ｐＲＳＶ／ＥＰＯ,ｐＣＭＶ／ＥＰＯ,在这３个表达载体的构建过程中对基因的转录起始效率、内含子的剪接、５′非翻译区和３′非翻译区对基因表达的影响等因素都加以考虑．用脂质体转染法分别将上述３个载体导入ＣＨＯ细胞,经瞬时表达,用ＥＬＩＳＡ方法检测,表达量分别为１９０ｍＩＵ／ｍｌ、１６０ｍＩＵ／ｍｌ、４４７ｍＩＵ／ｍｌ．用表达载体ｐＯＰ１３／ＥＰＯ转染ＣＨＯ－Ｋ１２细胞,在４００μｇ／ｍｌ的Ｇ４１８浓度下筛选稳定表达细胞克隆,获得了表达量约为１６０ＩＵ／１０６细胞（４８ｈ）的Ｃ１０细胞株．表达产物经Ｗｅｓｔｅｒｎｂｌｏｔ检测发现了ＥＰＯ阳性条带．用ＴＦ－１细胞对ＥＰＯ进行了生物活性检测,初步证实所表达的ＥＰＯ有生物活性．     

Hybridoma cell lines secreting monoclonal antibodies against foot-and-mouth disease virus. 1. Cell culturing requirements

The production of hybridoma cell lines secreting antibody against foot-and-mouth disease virus (FMDV) was more difficult than the production of similar cell lines secreting antibody against vesicular stomatitis virus or measles virus. A rapid and efficient protocol for the selection and culturing of 'anti-FMDV' hybridoma cultures was therefore developed and is described. This required the determination of the optimal culture medium (commercially available), source of serum supplement, line of myeloma cells, type of culture and routine for the subculturing of the hybridoma cells. The protocol consisted of fusion between immune splenocytes and NS-1 mouse myeloma cells, seeding into the wells of 24-well (24W) plates, culturing in RMPI 1640 medium supplemented with either foetal or donor calf serum, and passaging through 24W plates, 6W plates and 100 ml flasks (20 ml medium), respectively. The time at which aminopterin was added to kill unfused myeloma cells was also critical, with the optimum time being 24 h after fusion. In contrast, the B lymphocyte growth stimulant (2-mercaptoethanol) had no beneficial effects on the growth of the hybridomas.     

Production of H-Y antibody in the ascites fluid of mouse and localization of the antigen on cells and tissues

A procedure is described for the production of large amounts of ascites fluid containing specific H-Y antibody. The distribution of H-Y antigen on mouse epididymal spermatozoa, thymocytes, and splenocytes was carried out using this specific antibody in the microcytotoxicity test and ELISA. Employing the indirect immunofluorescent technique, the H-Y antigen was localized on the acrosomal membrane of mouse epididymal and washed ejaculated human spermatozoa and on the entire membrane of mouse splenocytes and thymocytes. Immunohistochemical localization of the antigen in the testicular section indicated its presence in the cytoplasm of Leydig cells and on the membrane of Sertoli cells and sperm heads.     

Identification and differentiation of Panax species using ELISA, RAPD and eastern blotting

Immunochemical and genetic methods have been developed in order to distinguish Panax spp. With the aim of establishing immunochemical methods, two hybridomas (3H4 and 5H8), each secreting a monoclonal antibody (MAb) against proteins of Panax ginseng, were prepared by fusing splenocytes immunized with two kinds of ginseng water-soluble fractions and a hypoxanthine-thymidine-aminopterin-sensitive mouse myeloma cell line, P3-X63-Ag8-U1. MAb 3H4 cross-reacted with four Panax spp., whereas the MAb 5H8 cross-reacted with P. ginseng in the enzyme-linked immunosorbent assay (ELISA). ELISA and western blotting methods using a ginseng water-soluble fraction as the solid-phase antigen were developed for the unambiguous authentication of P. ginseng. A combination of random amplified polymorphic DNA (RAPD) and eastern blotting analyses using anti-ginsenoside Rb1 and Rgl monoclonal antibodies was used for the identification of P. notoginseng, P. quinquefolius and P. japonicus. RAPD can be used to differentiate the species of Panax from each other. An important parameter used for differentiating P. notoginseng is the absence of ginsenoside Rc in the extract of P. notoginseng with eastern blotting. The combination of these methods enabled a reliable identification of Panax spp.     

Cloning and expression of a chimeric antibody directed against the human transferrin receptor

The cloning, construction and expression of chimeric Ig genes, encoding a mAb directed against the human transferrin receptor, is described. From a mouse hybridoma cell line, secreting an antitransferrin receptor antibody, mRNA was prepared and converted into cDNA using Ig-specific oligonucleotides. H and L chain encoding cDNA fragments were isolated and sequenced. Chimeric genes were constructed by linking the murine V region cDNA fragments to human C region exons. After sequential transfection of nonproducing mouse hybridoma cells with the expression vectors containing the chimeric H and L chain genes, antibody secreting transfectomas were obtained. ELISA and immunoblot analysis clearly demonstrate the secretion of human kappa- and gamma-1 chain. Flow microfluorimetry analysis of the chimeric antibody shows that the Ag-binding capacity has been retained. The chimeric antibody most likely will be less immunogenic then the original mouse antibody when used in human cancer therapy.     

Production of a bi-specific monoclonal antibody recognizing mouse kappa light chains and horseradish peroxidase. Applications in immunoassays

The production of a bi-specific monoclonal antibody that simultaneously recognizes mouse kappa light chains and horseradish peroxidase (HRP) for use as a general developing reagent in a wide variety of immunobased techniques is described. This antibody, named McC10, was produced by the fusion of an aminopterin-sensitive interspecies hybridoma which secretes rat monoclonal antibodies against HRP (RAP2.Ag) and splenocytes from a rat immunized with whole mouse immunoglobulin (Ig)G. The hybrid-hybridoma generated from this fusion expresses and secretes rat Igs of the IgG1 and IgG2a subclasses, as determined by radial immunodiffusion. In competitive binding solid-phase enzymatic assays, McC10 was found to cross-react with all four mouse IgG subclasses as well as mouse kappa light chains. In contrast, in this type of assay, McC10 did not appear to recognize mouse IgA, IgM or lambda light chains. However, IgM-bearing kappa light chains were recognized by immunocytochemistry. Epitope specificity of this bi-specific antibody was more clearly determined on immunoblots where McC10 was found to exclusively recognize mouse kappa light chains and display no cross-reactivity with mouse Ig heavy chains nor with kappa light chains from rat or rabbit. In addition, McC10 was used successfully in two-step immunocytochemistry (ICC) for the localization of enkephalin, nerve growth factor (NGF) receptor and paired helical filament-immunoreactive sites in rat brain, rat skin and human brain, respectively, using mouse IgG's and IgM's as primary antibodies. McC10 compared favourably with peroxidase-anti-peroxidase (PAP) ICC with respect to sensitivity but was markedly superior with respect to specificity when used in fixed human brain or rat skin.(ABSTRACT TRUNCATED AT 250 WORDS)     

Formation of monoclonal antibody against a major ginseng component, ginsenoside Rb1 and its characterization

The ratio of hapten and bovine serum albumin in an antigen conjugate was determined by matrix-assisted laser desorption/ionization mass spectrometry. A hybridoma secreting monoclonal antibody against ginsenoside Rb1 was produced by fusing splenocytes immunized with a ginsenoside Rb1- bovine serum albumin conjugate with HAT-sensitive mouse myeloma cell line, P3-X63-Ag8-653. A very small cross-reaction appeared with ginsenoside Rc and ginsenoside Rd. The full measuring range of the assay extends from 20 ngml-1 to 400 ngml-1 of ginsenoside Rb1. This revised version was published online in July 2006 with corrections to the Cover Date.     

Characterization of a monoclonal antibody to bovine xanthine oxidase.

The isolation of a hybridoma cell line, C-41, secreting monoclonal antibody to bovine xanthine oxidase (EC 1.2.3.2), is described. The specificity of this antibody was determined by solid-phase immunoassay, immunoblotting procedures, affinity chromatography, immunoelectrophoresis and precipitation techniques. The results are compared with those obtained in similar specificity studies on a previously described monoclonal antibody secreted by hybridoma cell line A-94 [Mather, Nace, Johnson & Goldsby (1980) Biochem. J. 188, 925-928]. This latter antibody appears to bind to xanthine oxidase only when the enzyme is immobilized on a solid support such as a plastic plate or nitrocellulose paper. Potential problems in the determination of the specificity of monoclonal antibodies, especially towards membrane proteins of unknown biological activity, are discussed.     

Studies of mouse immunoglobulin allotypes by reverse plaque assay: Detection of spleen cells secreting immunoglobulins with specific allotype in C57BL/6J mice

A reverse hemolytic plaque assay for the detection and enumeration of mouse spleen cells secreting immunoglobulins bearing a particular allotypic specificity is described. Sheep red blood cells (SRBC) coated with protein A or anti-mouse gamma globulin antibody were employed as indicator cells and an anti-allotype antibody was used as developer. A comparison of the efficiency of protein A, goat anti-mouse or rabbit anti-mouse gamma globulin antibody-coated SRBC as indicator cells in the plaque assay indicated that the rabbit anti-mouse gamma globulin-coated SRBC gave the best results in terms of number and morphology of the plaques. The number of indicator cells in the assay mixture also significantly affected the quality of the plaques formed. When the mouse spleen cells were assayed with the indicator cells and an anti-allotypic antibody as developer in presence of complement in a liquid medium, only those cells secreting the immunoglobulin of the given allotypic specificity formed hemolytic plaques.     

Monoclonal antibodies as neural cell surface markers

A comparison is made of the immunohistochemistry at the ultrastructural level of three monoclonal antibodies directed against surface components of CNS cells. Hybridomas secreting these antibodies were obtained from two cell fusions of a rat myeloma cell line and immune splenocytes derived from rats immunized either with primary mouse brain cultured cells or membrane components. In cultures one antibody, anti-BSP-2 (Brain Surface Protein-2), was preferentially directed against neurones while another, anti-BSP-3 (Brain Surface Protein-3), preferentially labeled astrocytes. In mouse cerebellar sections, both labeled the surface of Purkinje cells, granule cells and astrocytes. In addition a cytoplasm localization was apparent in granule cells and astrocytes. Another antibody anti-MESA-1 (Mouse Endothelial Surface Antigen-1) reacted exclusively with the surface of endothelial cells lining blood vessels. These data are discussed with reference to the biochemical nature of the corresponding antigens and to known glycoproteins of neural cell membranes.     

Production of a bi-specific monoclonal antibody recognizing mouse kappa light chains and horseradish peroxidase

Summary The production of a bi-specific monoclonal antibody that simultaneously recognizes mouse kappa light chains and horseradish peroxidase (HRP) for use as a general developing reagent in a wide variety of immunobased techniques is described. This antibody, named McC10, was produced by the fusion of an aminopterin-sensitive interspecies hybridoma which secretes rat monoclonal antibodies against HRP (RAP₂·Ag) and splenocytes from a rat immunized with whole mouse immunoglobulin (Ig)G. The hybrid-hybridoma generated from this fusion expresses and secretes rat Igs of the IgG₁ and IgG_2a subclasses, as determined by radial immunodiffusion. In competitive binding solid-phase enzymatic assays, McC10 was found to cross-react with all four mouse IgG subclasses as well as mouse kappa light chains. In contrast, in this type of assay, McC10 did not appear to recognize mouse IgA, IgM or lambda light chains. However, IgM-bearing kappa light chains were recognized by immunocytochemistry. Epitope specificity of this bi-specific antibody was more clearly determined on immunoblots where McC10 was found to exclusively recognize mouse kappa light chains and display no cross-reactivity with mouse Ig heavy chains nor with kappa light chains from rat or rabbit. In addition, McC10 was used successfully in two-step immunocytochemistry (ICC) for the localization of enkephalin, nerve growth factor (NGF) receptor and paired helical filament-immunoreactive sites in rat brain, rat skin and human brain, respectively, using mouse IgG's and IgM's as primary antibodies. McC10 compared favourably with peroxidase-anti-peroxidase (PAP) ICC with respect to sensitivity but was markedly superior with respect to specificity when used in fixed human brain or rat skin. This study demonstrates some of the potential advantages of using an epitope specific monoclonal bi-specific developing reagent like McC10 in an immunobased technique like ICC. Its potential use in a variety of other immunobased procedures is discussed.